Health & Medicine - Overview
The Museum's collections of medical science artifacts represent nearly all aspects of health and medical practice. Highlights include early X-ray apparatuses, such as one of Wilhelm Roentgen's tubes, penicillin mold from Alexander Fleming’s experiments, and Jonas Salk's original polio vaccine. More recent acquisitions include the first artificial heart implanted in a human, the earliest genetically engineered drugs, and materials related to David, the "Bubble Boy." Other artifacts range from artificial limbs and implant devices to bloodletting and dental instruments, beauty products, and veterinary equipment. The contents of a medieval apothecary shop and an 1890s drugstore form part of the collections, along with patent and alternative medicines. The collections also document the many differing perspectives on health and medical issues, from patients, family members, doctors, nurses, medical students, and out-of-the-mainstream health practitioners.
"Health & Medicine - Overview" showing 6 items.
Intron A; Interferon Alfa-2B Recombinant, 5 million IU
- Description (Brief)
- Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
- Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
- Object consists of a cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
- Location
- Currently not on view
- date made
- 1988
- maker
- Schering Corporation
- ID Number
- 1987.0781.01
- accession number
- 1987.0781
- catalog number
- 1987.0781.01
- Data Source
- National Museum of American History, Kenneth E. Behring Center
Intron A; Interferon Alfa-2B Recombinant, 5 million IU
- Description (Brief)
- Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
- Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
- Object consists of a cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
- Location
- Currently not on view
- date made
- 1988
- maker
- Schering Corporation
- ID Number
- 1987.0781.02
- catalog number
- 1987.0781.02
- accession number
- 1987.0781
- Data Source
- National Museum of American History, Kenneth E. Behring Center
Intron A; Interferon Alfa-2B Recombinant, 10 million IU
- Description (Brief)
- Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
- Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
- Object consists of a cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
- Location
- Currently not on view
- date made
- 1988
- maker
- Schering Corporation
- ID Number
- 1987.0781.03
- accession number
- 1987.0781
- catalog number
- 1987.0781.03
- Data Source
- National Museum of American History, Kenneth E. Behring Center
Intron A; Interferon Alfa-2B Recombinant, 10 million IU
- Description (Brief)
- Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
- Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
- Object consists of cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
- Location
- Currently not on view
- date made
- 1988
- maker
- Schering Corporation
- ID Number
- 1987.0781.04
- accession number
- 1987.0781
- catalog number
- 1987.0781.04
- Data Source
- National Museum of American History, Kenneth E. Behring Center
Intron A; Interferon Alfa-2B Recombinant, 25 million IU
- Description (Brief)
- Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
- Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
- Object consists of a cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
- Location
- Currently not on view
- date made
- 1988
- maker
- Schering Corporation
- ID Number
- 1987.0781.05
- accession number
- 1987.0781
- catalog number
- 1987.0781.05
- Data Source
- National Museum of American History, Kenneth E. Behring Center
Intron A; Interferon Alfa-2B Recombinant, 25 million IU
- Description (Brief)
- Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
- Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
- Object consists of a cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
- Location
- Currently not on view
- date made
- 1988
- maker
- Schering Corporation
- ID Number
- 1987.0781.06
- catalog number
- 1987.0781.06
- accession number
- 1987.0781
- Data Source
- National Museum of American History, Kenneth E. Behring Center